These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 18004136)
1. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. Lindley SE; Carlson EB; Hill K J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136 [TBL] [Abstract][Full Text] [Related]
2. Treatment of civilian and combat-related posttraumatic stress disorder with topiramate. Andrus MR; Gilbert E Ann Pharmacother; 2010 Nov; 44(11):1810-6. PubMed ID: 20923947 [TBL] [Abstract][Full Text] [Related]
3. Topiramate in combat-related posttraumatic stress disorder. Alderman CP; McCarthy LC; Condon JT; Marwood AC; Fuller JR Ann Pharmacother; 2009 Apr; 43(4):635-41. PubMed ID: 19336652 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J; Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356 [TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder. Mello MF; Yeh MS; Barbosa Neto J; Braga LL; Fiks JP; Mendes DD; Moriyama TS; Valente NL; Costa MC; Mattos P; Bressan RA; Andreoli SB; Mari JJ BMC Psychiatry; 2009 May; 9():28. PubMed ID: 19480669 [TBL] [Abstract][Full Text] [Related]
6. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. Berlant JL BMC Psychiatry; 2004 Aug; 4():24. PubMed ID: 15315714 [TBL] [Abstract][Full Text] [Related]
7. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ; Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971 [TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Davis LL; Ward C; Rasmusson A; Newell JM; Frazier E; Southwick SM Psychopharmacol Bull; 2008; 41(1):8-18. PubMed ID: 18362867 [TBL] [Abstract][Full Text] [Related]
10. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. Davis LL; Davidson JR; Ward LC; Bartolucci A; Bowden CL; Petty F J Clin Psychopharmacol; 2008 Feb; 28(1):84-8. PubMed ID: 18204347 [TBL] [Abstract][Full Text] [Related]
11. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial. Villarreal G; Calais LA; CaƱive JM; Lundy SL; Pickard J; Toney G Psychopharmacol Bull; 2007; 40(2):6-18. PubMed ID: 17514183 [TBL] [Abstract][Full Text] [Related]
12. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J; Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844 [TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type. Roy Chengappa K; Kupfer DJ; Parepally H; John V; Basu R; Buttenfield J; Schlicht P; Houck P; Brar JS; Gershon S Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276 [TBL] [Abstract][Full Text] [Related]
14. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Raskind MA; Peskind ER; Hoff DJ; Hart KL; Holmes HA; Warren D; Shofer J; O'Connell J; Taylor F; Gross C; Rohde K; McFall ME Biol Psychiatry; 2007 Apr; 61(8):928-34. PubMed ID: 17069768 [TBL] [Abstract][Full Text] [Related]
15. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial. Behdani F; Hebrani P; Rezaei Ardani A; Rafee E Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. Tucker P; Trautman RP; Wyatt DB; Thompson J; Wu SC; Capece JA; Rosenthal NR J Clin Psychiatry; 2007 Feb; 68(2):201-6. PubMed ID: 17335317 [TBL] [Abstract][Full Text] [Related]
18. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials. Connor GS; Edwards K; Tarsy D Clin Neuropharmacol; 2008; 31(2):97-103. PubMed ID: 18382182 [TBL] [Abstract][Full Text] [Related]
19. The impact of topiramate on health-related quality of life indicators in chronic migraine. Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ Headache; 2007; 47(10):1398-408. PubMed ID: 18052949 [TBL] [Abstract][Full Text] [Related]
20. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. Martenyi F; Brown EB; Caldwell CD J Clin Psychopharmacol; 2007 Apr; 27(2):166-70. PubMed ID: 17414240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]